title: Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood.
authors.affiliation: 3rd Department of Internal Medicine, Semmelweis University , Budapest , Hungary.
authors.forename: H
authors.initials: H
authors.lastname: Farkas
authors.forename: N
authors.initials: N
authors.lastname: Veszeli
authors.forename: D
authors.initials: D
authors.lastname: Csuka
authors.forename: G
authors.initials: G
authors.lastname: Temesszentandrási
authors.forename: F
authors.initials: F
authors.lastname: Tóth
authors.forename: L
authors.initials: L
authors.lastname: Kőszegi
authors.forename: L
authors.initials: L
authors.lastname: Varga
mesh_terms: D000328:Adult; D054179:Angioedemas, Hereditary / Q000188:drug therapy*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D050718:Complement C1 Inhibitor Protein / Q000627:therapeutic use*; D003613:Danazol / Q000009:adverse effects; D004965:Estrogen Antagonists / Q000009:adverse effects; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D050718:Complement C1 Inhibitor Protein; D004965:Estrogen Antagonists; D014148:Tranexamic Acid; D003613:Danazol